1.
Zadro Y, Lafaurie M, Sommet A, Lapeyre-Mestre M, Moulis G. No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study. Haematologica 2026; 111(8):2824-2827; https://doi.org/10.3324/haematol.2025.300199.